Associations Between Changes in Glucagon-Like Peptide-1 and Bodyweight Reduction in Patients Receiving Acarbose or Metformin Treatment

Journal of Diabetes - United States
doi 10.1111/1753-0407.12486
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Relationship Between Sleep and Glucagon-Like Peptide 1 in Patients With Abnormal Glucose Tolerance

Journal of Sleep Research
MedicineBehavioral NeuroscienceCognitive Neuroscience
2017English

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Equine Glucagon-Like Peptide-1 Receptor Physiology

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Glucagon-Like Peptide-1 Receptor (GLP-1R) Signaling Ameliorates Dysfunctional Immunity in COPD Patients

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2018English

Glucagon-Like Peptide 1 Regulates Adipogenesis in 3t3-L1 Preadipocytes

International Journal of Molecular Medicine
MedicineGenetics
2013English

Cardiovascular and Hemodynamic Effects of Glucagon-Like Peptide-1

Reviews in Endocrine and Metabolic Disorders
EndocrinologyMetabolismDiabetes
2014English

Glucagon-Like Peptide-1 (7-37) Augments Insulin Release in Elderly Patients With Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy